Clinical Trials Logo

Hypokinesia clinical trials

View clinical trials related to Hypokinesia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05470751 Completed - Multiple Sclerosis Clinical Trials

GentleCathâ„¢ for Men Intermittent Catheter With FeelCleanâ„¢ Technology

Start date: February 2, 2023
Phase:
Study type: Observational

Male self catherterisng observational study.

NCT ID: NCT05359484 Completed - Clinical trials for Detrusor Underactivity

Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction

Start date: January 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

To determine the significance of delta Q value (Qmax - Qave) in discrimination between BOO and DU, to avoid invasive studies (pressure flow studies (PFSs)) and replace them with noninvasive study (uroflowmetry).

NCT ID: NCT04981080 Completed - Clinical trials for Bladder Outlet Obstruction

DU and BOO in Women With and Without Symptoms of VD

Start date: February 1, 2005
Phase:
Study type: Observational

Women with symptoms of voiding dysfunction may be associated with detrusor underactivity or bladder outlet obstruction. However, the prevalence of detrusor underactivity and bladder outlet obstruction remained obscure. Thus, the aim of this study was to elucidate the prevalence of detrusor underactivity and bladder outlet obstruction in women with and without symptoms of voiding dysfunction.

NCT ID: NCT04974034 Completed - Parkinson Disease Clinical Trials

Movement Disorders Analysis Using a Deep Learning Approach

Start date: June 1, 2019
Phase:
Study type: Observational

Bradykinesia is a key parkinsonian feature yet subjectively assessed by the MDS-UPDRS score, making reproducible measurements and follow-up challenging. In a Movement Disorder Unit, the investigators acquired a large database of videos showing parkinsonian patients performing Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III protocols. Using a Deep Learning approach on these videos, the investigators aimed to develop a tool to compute an objective score of bradykinesia from the three upper limb tests described in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III.

NCT ID: NCT04824820 Completed - Clinical trials for Urinary Incontinence

Improving Female Sexual Wellness

Start date: April 10, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of commercially available genital vibrator use on sexual health, female pelvic floor disorders, and overall quality of life among a diverse population of women.

NCT ID: NCT04336280 Completed - Clinical trials for Detrusor Underactivity

Detrusor Underactivity: Presentation and Urodynamic Characteristics

Start date: January 20, 2020
Phase:
Study type: Observational

Detrusor underactivity (DU) is a known disease of the muscles of the urinary bladder that defined as a weak contraction of the muscle resulting in a failure to achieve complete bladder emptying. Recently, DU as a cause of Lower Urinary Tract Symptoms in both men and women has been increasingly gaining attention. There is a major issue in differentiation of underactive bladder symptoms and other causes of lower urinary tract symptoms such as detrusor hyperactivity and impaired contractility (DHIC), hypersensitive bladder (HSB), detrusor overactivity (DO), bladder outlet obstruction (BOO) and Dysfunctional Voiding (DV). Urodynamics (UDS) is the standard diagnostic tool, it includes invasive recording of the pressure that is produced when the bladder muscle contracts via pressure sensors introduced in the urinary bladder through special types of urethral catheters. This study aims to determine the prevalence of DU along with its symptomatic and urodynamics (UDS) characteristics of DU in Jordanian population through a retrospective chart review.

NCT ID: NCT04184752 Completed - Voiding Disorders Clinical Trials

Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Without Cystocele

Start date: April 1, 1996
Phase:
Study type: Observational

Women with symptoms of voiding dysfunction may be associated with detrusor underactivity (DU) or bladder outlet obstruction (BOO). The treatment strategies are different between DU and BOO. In general, urodynamic/videourodynamic studies are important for differential diagnosis. However, urodynamic/videourodynamic studies are invasive. The investigators are interested in whether there were specific symptoms or measurements that can be used for initial differential diagnosis between DU and BOO. Thus, the aim of this study was to elucidate the prevalence of DU and BOO in each age group and elucidate the clinical and urodynamic differences between the DU, BOO and non-DU/BOO groups.

NCT ID: NCT04184128 Completed - Cystocele Clinical Trials

Detrusor Underactivity and Bladder Outlet Obstruction in Women With Cystocele

Start date: November 1, 2010
Phase:
Study type: Observational

Women with cystocele may be associated with detrusor underactivity (DU) or bladder outlet obstruction (BOO). However, the impact of cystocele repair on the rates of DU and BOO remained obscure. Thus, the aim of this study was to elucidate the prevalence of DU and BOO in each age group and elucidate the impact of cystocele repair on the rates of DU and BOO.

NCT ID: NCT04161183 Completed - Clinical trials for Detrusor Underactivity

Extracoporeal Shock Wave Therapy (ESWT) for the Treatment of Detrusor Underactivity/ Underactive Bladder (DU/UAB)

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of ESWT for the treatment of patients with DU/UAB

NCT ID: NCT03954769 Completed - Clinical trials for Hyperactive Delirium

A Pilot Study of "Stanford Proxy Test for Delirium" (S-PTD)

Start date: February 2014
Phase:
Study type: Observational

Although there are several tools available for the screening of delirium among the medically ill, they all have some limitations. First, none of the available tools have been validated against newly developed and published DSM-5 (Diagnostic and Statistical Manual) or ICD-10 (International Statistical Classification of Diseases and Related Health Problems) criteria. Additionally, all the screening/diagnostic tools presently available have the same limitation, they all require significant patient involvement and participation (e.g., questions and activities) in order to complete the assessment. By definition, delirium is a neuropsychiatric disorder characterized by disturbance in attention and awareness, and additional disturbance in cognition (e.g., memory deficit, disorientation), language, visuospatial ability, or perception. The intrinsic characteristics of delirium seem to interfere with the patient's ability to participate and complete many of the tasks associated with delirium evaluation itself. Finally, most available tools seem to narrowly focus on some neurocognitive areas of delirium, but not being comprehensive enough. In contrast, the S-PTD is designed so it can be completed by the nursing staff caring for the patients, the medical personnel most intimately involved with the care and aware of the behaviors exhibited by the patient during the course of their hospital stay. The idea is that nurses will complete the screening tool (hence the term "by proxy"), based on the behaviors and interactions observed during the course of a conventional "nursing shift", to determine whether the patient meets current neuropsychiatric criteria for the diagnosis of delirium.